LABTVSSCTX• 12 Months (Normalized)
LABT vs SCTX (Lakewood-Amedex Biotherapeutics Inc. vs Scribe Therapeutics Inc.)
Showing Closing Date Range from Sep 30, 2025 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
LABT Performance $0.99
-98.86%
Lakewood-Amedex Biotherapeutics Inc.
Normalized Baseline0.00%
SCTX Performance $21.28
+%
Scribe Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin SCTX LEADS
-98.86 pts
SCTX outperforming by 98.86 percentage points
LABTSCTX
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
LABT SCTX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(110 dates)
| Date | LABT Price | LABT Gain (%) | SCTX Price | SCTX Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $0.99 | -98.86% | $- | - | |
| Sep 28, 2026 | $1.15 | -98.67% | $- | - | |
| Sep 25, 2026 | $1.67 | -98.07% | $21.28 | +12.18% | -110.25% |
| Sep 24, 2026 | $1.83 | -97.88% | $21.61 | +13.92% | -111.80% |
| Sep 23, 2026 | $1.78 | -97.94% | $26.53 | +39.85% | -137.79% |
| Sep 22, 2026 | $1.99 | -97.70% | $28.07 | +47.97% | -145.67% |
| Sep 21, 2026 | $2.05 | -97.63% | $28.05 | +47.87% | -145.50% |
| Sep 18, 2026 | $1.99 | -97.70% | $33.00 | +73.96% | -171.66% |
| Sep 17, 2026 | $1.86 | -97.85% | $32.14 | +69.43% | -167.28% |
| Sep 16, 2026 | $2.09 | -97.58% | $29.10 | +53.40% | -150.98% |
| Sep 15, 2026 | $2.17 | -97.49% | $31.66 | +66.90% | -164.39% |
| Sep 14, 2026 | $2.12 | -97.55% | $29.42 | +55.09% | -152.64% |
| Sep 11, 2026 | $2.22 | -97.43% | $29.74 | +56.77% | -154.20% |
| Sep 10, 2026 | $2.05 | -97.63% | $29.47 | +55.35% | -152.98% |
| Sep 09, 2026 | $2.32 | -97.32% | $29.41 | +55.03% | -152.35% |
Page 1 of 8